Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients
- PMID: 26769460
- DOI: 10.1002/mds.26433
Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients
Abstract
Background: Reduced expression of lysosomal-associated membrane protein 2a and heatshock-cognate 70 proteins, involved in chaperone-mediated autophagy and of glucocerebrosidase, is reported in PD brains. The aim of this study was to identify systemic alterations in lysosomal-associated membrane protein 2a, heatshock cognate-70, and glucocerebrosidase levels/activity in peripheral blood mononuclear cells from PD patients.
Methods: Protein/mRNA levels were assessed in PD patients from genetically undetermined background, alpha-synuclein (G209A/A53T), or glucocerebrosidase mutation carriers and age-/sex-matched controls.
Results: Heatshock cognate 70 protein levels were reduced in all PD groups, whereas its mRNA levels were decreased only in the genetically undetermined group. Glucocerebrosidase protein levels were decreased only in the genetic PD groups, whereas increased mRNA levels and decreased activity were detected only in the glucocerebrosidase mutation group.
Conclusions: Reduced heatshock cognate-70 levels are suggestive of an apparent systemic chaperone-mediated autophagy dysfunction irrespective of genetic background. Glucocerebrosidase activity may serve as a screening tool to identify glucocerebrosidase mutation carriers with PD.
Keywords: Hsc70; Parkinson's disease; alpha-synuclein; chaperone-mediated autophagy (CMA); glucocerebrosidase (GCase); lysosome.
© 2015 International Parkinson and Movement Disorder Society.
Similar articles
-
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.Brain. 2014 Mar;137(Pt 3):834-48. doi: 10.1093/brain/awt367. Epub 2014 Jan 28. Brain. 2014. PMID: 24477431 Free PMC article.
-
Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.Cell Death Dis. 2013 Mar 14;4(3):e545. doi: 10.1038/cddis.2013.73. Cell Death Dis. 2013. PMID: 23492776 Free PMC article.
-
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease.Brain Res. 2014 Feb 10;1546:46-52. doi: 10.1016/j.brainres.2013.12.017. Epub 2013 Dec 19. Brain Res. 2014. PMID: 24361989
-
Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.Mov Disord. 2016 Feb;31(2):178-92. doi: 10.1002/mds.26477. Epub 2016 Jan 27. Mov Disord. 2016. PMID: 26813776 Review.
-
The relationship between glucocerebrosidase mutations and Parkinson disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860875 Free PMC article. Review.
Cited by
-
Neurotoxicity of diesel exhaust extracts in zebrafish and its implications for neurodegenerative disease.Sci Rep. 2022 Nov 12;12(1):19371. doi: 10.1038/s41598-022-23485-2. Sci Rep. 2022. PMID: 36371460 Free PMC article.
-
Glycosphingolipids and neuroinflammation in Parkinson's disease.Mol Neurodegener. 2020 Oct 17;15(1):59. doi: 10.1186/s13024-020-00408-1. Mol Neurodegener. 2020. PMID: 33069254 Free PMC article. Review.
-
Dysregulation of autophagy and mitochondrial function in Parkinson's disease.Transl Neurodegener. 2016 Oct 31;5:19. doi: 10.1186/s40035-016-0065-1. eCollection 2016. Transl Neurodegener. 2016. PMID: 27822367 Free PMC article. Review.
-
Abnormal Vacuole Membrane Protein-1 Expression in Parkinson's Disease Patients.Front Neurosci. 2022 Apr 6;16:760932. doi: 10.3389/fnins.2022.760932. eCollection 2022. Front Neurosci. 2022. PMID: 35464320 Free PMC article.
-
Parkinson's disease therapy: what lies ahead?J Neural Transm (Vienna). 2023 Jun;130(6):793-820. doi: 10.1007/s00702-023-02641-6. Epub 2023 May 5. J Neural Transm (Vienna). 2023. PMID: 37147404 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous